APA

Robles C., Kim K. M., Oken M. M., Bennett J. M., Letendre L., Wiernik P. H., O'Connell M. J. & Cassileth P. A. (20000824). Low-dose cytarabine maintenance therapy vs observation after remission induction in advanced acute myeloid leukemia: an Eastern Cooperative Oncology Group Trial (E5483). : Leukemia.

Chicago

Robles C, Kim K M, Oken M M, Bennett J M, Letendre L, Wiernik P H, O'Connell M J and Cassileth P A. 20000824. Low-dose cytarabine maintenance therapy vs observation after remission induction in advanced acute myeloid leukemia: an Eastern Cooperative Oncology Group Trial (E5483). : Leukemia.

Harvard

Robles C., Kim K. M., Oken M. M., Bennett J. M., Letendre L., Wiernik P. H., O'Connell M. J. and Cassileth P. A. (20000824). Low-dose cytarabine maintenance therapy vs observation after remission induction in advanced acute myeloid leukemia: an Eastern Cooperative Oncology Group Trial (E5483). : Leukemia.

MLA

Robles C, Kim K M, Oken M M, Bennett J M, Letendre L, Wiernik P H, O'Connell M J and Cassileth P A. Low-dose cytarabine maintenance therapy vs observation after remission induction in advanced acute myeloid leukemia: an Eastern Cooperative Oncology Group Trial (E5483). : Leukemia. 20000824.